Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Immunis Inc.

Immunis Honored with the National Academy of Medicine’s 2025 Healthy Longevity Catalyst Award
From Immunis Inc.
Via Business Wire
Immunis Successfully Completes its Phase 1/2a Clinical Trial Targeting Muscle Atrophy
From Immunis Inc.
Via Business Wire
Immunis Discusses with Experts Why the Immune System is the Key to Human Healthspan
From Immunis Inc.
Via Business Wire
Immunis Publishes Research Showing Secretomes Improve Metabolism and Muscle While Reducing Fat in Aged Models
From Immunis Inc.
Via Business Wire
Immunis Wins Corporate LiveWire’s 2023 “Innovation and Excellence Award”
From Immunis Inc.
Via Business Wire
Immunis Chairman Dr. Hans Keirstead to Speak at the Ending Age-Related Diseases Summit
From Immunis Inc.
Via Business Wire
Immunis Recruits Individuals with Muscle Atrophy for Phase 1/2a Clinical Trial
From Immunis Inc.
Via Business Wire
Immunis Initiates Patient Enrollment for Muscle Atrophy Phase 1/2a Clinical Trial
From Immunis Inc.
Via Business Wire
Immunis Signs Clinical Trial Agreement with CIRM Alpha Stem Cell Clinics
From Immunis Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.